These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 3844370

  • 1. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F, Kijlstra A.
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [Abstract] [Full Text] [Related]

  • 2. Modulation of classical C3 convertase of complement by tear lactoferrin.
    Kijlstra A, Jeurissen SH.
    Immunology; 1982 Oct; 47(2):263-70. PubMed ID: 6922088
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 4. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 5. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM, Gleich GJ.
    J Immunol; 1988 Mar 01; 140(5):1605-10. PubMed ID: 3346544
    [Abstract] [Full Text] [Related]

  • 6. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK, Holme E, Hamilton E, Whaley K.
    Clin Exp Immunol; 1985 Apr 01; 60(1):169-77. PubMed ID: 3159522
    [Abstract] [Full Text] [Related]

  • 7. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.
    Rainard P.
    Immunology; 1993 Aug 01; 79(4):648-52. PubMed ID: 8406591
    [Abstract] [Full Text] [Related]

  • 8. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov 01; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 9. Complement fixation in acute serum sickness: assembly of glomerular-bound C3-convertase.
    Bartolotti SR, Peters DK.
    Clin Exp Immunol; 1979 Sep 01; 37(3):391-8. PubMed ID: 389495
    [Abstract] [Full Text] [Related]

  • 10. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P, Joiner KA, Hammer CH, Frank MM, Tosi R.
    J Immunol; 1987 May 15; 138(10):3385-91. PubMed ID: 2952716
    [Abstract] [Full Text] [Related]

  • 11. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA.
    Clin Exp Immunol; 1983 Sep 15; 53(3):541-6. PubMed ID: 6604604
    [Abstract] [Full Text] [Related]

  • 12. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW, Waage C, Fure H, Brekke OL, Sfyroera G, Lambris JD, Mollnes TE.
    Mol Immunol; 2007 Mar 15; 44(8):1819-26. PubMed ID: 17101176
    [Abstract] [Full Text] [Related]

  • 13. C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.
    Garred P, Michaelsen TE, Aase A, Mollnes TE.
    J Immunol; 1990 Jan 01; 144(1):198-203. PubMed ID: 2295791
    [Abstract] [Full Text] [Related]

  • 14. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 15. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 16. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov 01; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 17. The role of C1, C1-inactivator and C4 in modulating immune precipitation.
    Schifferli JA, Steiger G, Schapira M.
    Clin Exp Immunol; 1985 Jun 01; 60(3):605-12. PubMed ID: 4017288
    [Abstract] [Full Text] [Related]

  • 18. The effect of lactoferrin on complement mediated modulation of immune complex size.
    Kulics J, Kijlstra A.
    Immunol Lett; 1987 Apr 01; 14(4):349-53. PubMed ID: 3583326
    [Abstract] [Full Text] [Related]

  • 19. Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.
    Beebe DP, Schreiber RD, Cooper NR.
    J Immunol; 1983 Mar 01; 130(3):1317-22. PubMed ID: 6822737
    [Abstract] [Full Text] [Related]

  • 20. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec 01; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.